This follows a previous article with a general summary of the two medication studies for BPD presented here: http://pdan.org/drug-trials-encouraging-results-for-bpd/ SEROQUEL XR (OLANZAPINE) STUDY FOR BPD, 2010-2013 “Comparison of Low and Moderate Dosages of Extended- Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial”, by Donald Black, Mary Zanarini, Ann […]
Read more →
RECENT COMMENTS